Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field. | Front Nucl Med | 2023 | 39355036 | PubTator, text mining | PubMed |
| Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [68Ga]Ga-RM2-A Head-to-Head Pilot Comparison with [68Ga]Ga-PSMA-11. | Cancers (Basel) | 2023 | 38201600 | PubTator, text mining | PubMed |
| Nanoparticle-mediated active and passive drug targeting in oral squamous cell carcinoma: current trends and advances. | Nanomedicine (Lond) | 2023 | 38197397 | PubTator, text mining | PubMed |
| A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma. | Front Endocrinol (Lausanne) | 2023 | 38155952 | PubTator, text mining | PubMed |
| Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). | Int J Mol Sci | 2023 | 38139219 | PubTator, text mining | PubMed |
| Advances in Intraoperative Glioma Tissue Sampling and Infiltration Assessment. | Brain Sci | 2023 | 38137085 | PubTator, text mining | PubMed |
| Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. | Discov Nano | 2023 | 38112849 | PubTator, text mining | PubMed |
| Kappa opioid agonists in the treatment of itch: just scratching the surface? | Itch (Phila) | 2023 | 38099236 | PubTator, text mining | PubMed |
| GRP/GRPR signaling pathway aggravates hyperuricemia-induced renal inflammation and fibrosis via ABCG2-dependent mechanisms. | Biochem Pharmacol | 2023 | 38084678 | PubTator, text mining | PubMed |
| Regulated necrosis role in inflammation and repair in acute kidney injury. | Front Immunol | 2023 | 38077379 | PubTator, text mining | PubMed |
| Towards Cancer Nanoradiopharmaceuticals-Radioisotope Nanocarrier System for Prostate Cancer Theranostics Based on Radiation-Synthesized Polymer Nanogels. | Cancers (Basel) | 2023 | 38067350 | PubTator, text mining | PubMed |
| Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer. | Adv Pharm Bull | 2023 | 38022814 | PubTator, text mining | PubMed |
| GRPR-targeting radiotheranostics for breast cancer management. | Front Med (Lausanne) | 2023 | 38020178 | PubTator, text mining | PubMed |
| Bombesins: A New Frontier in Hybrid Compound Development. | Pharmaceutics | 2023 | 38004575 | PubTator, text mining | PubMed |
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. | Mol Pharm | 2023 | 37978936 | PubTator, text mining | PubMed |
| Interaction of βL- and γ-Crystallin with Phospholipid Membrane Using Atomic Force Microscopy. | Int J Mol Sci | 2023 | 37958704 | PubTator, text mining | PubMed |
| Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT. | J Nucl Med | 2023 | 37934025 | PubTator, text mining | PubMed |
| A panoramic view of hospitalized young children in the metropolitan area of the valley of Mexico during COVID-19. | IJID Reg | 2023 | 37928801 | PubTator, text mining | PubMed |
| The Hybrid Nano-Biointerface between Proteins/Peptides and Two-Dimensional Nanomaterials. | Molecules | 2023 | 37894543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=9